Drimva

Formation Bio

Senior Director of Asset Quality Assurance

$235K–$307K

Boston, MA +3 · Director · Full-time · Posted Jun 5, 2026

Location
Boston, MA
New York, NY
116 Huntington Ave., Back Bay, Boston, MA, 02116
16 E 34th St., New York City, NY, 10016
Education
Bachelor’s or advanced degree in a scientific, engineering, or related discipline.

About the job

Leads asset-level quality assurance strategy, embedding risk-based quality frameworks across drug development, due diligence, regulatory readiness, and commercialization.

What you'll do

  • Integrate Quality by Design into clinical, nonclinical, and CMC development plans, including those using AI-enabled technology and real-world data.
  • Assess quality risks and external assets during due diligence, and establish fit-for-purpose controls and mitigations.
  • Lead audit-readiness and apply global regulatory expectations to support asset development, commercialization, and strategic transitions.

What they ask for

  • Bachelor’s or advanced degree in a scientific, engineering, or related discipline.
  • Extensive multidisciplinary GxP experience in biopharma quality assurance leadership, including proficiency across GLP, GCP, and GMP.
  • Experience conducting quality due diligence for R&D and early-stage clinical assets, and knowledge of commercialization inspections, product launch, and post-approval commitments.
  • Track record managing program-level risk frameworks and leading assets through major regulatory inflection points and strategic transactions.

Nice to have

  • Experience at a fast-paced biotech that has transitioned from early-stage to commercial.

Pay

$235,000 - $307,000 (USD, total pay)

Tools

AI-enabled technology, real-world data, FDA, EMA, ICH, GLP, GCP, GMP

AI focus

Applies quality frameworks and regulatory expectations to AI-enabled drug development and digital environments.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)